(Q80201780)
Statements
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate (English)
R N Maini
P C Taylor
J Szechinski
J Bröll
G Balint
P Emery
F Raemen
J Petersen
J Smolen
D Thomson
T Kishimoto
CHARISMA Study Group
1 September 2006